The use of humanized antibodies against a surface protein of HSV, in addition to what, can be used as a protein therapeutic to treat HSV?
Understand the Problem
The question presents an incomplete statement about using humanized antibodies and another element as a protein therapeutic to treat HSV and asks us to determine what that missing element might be. It's essentially fill-in-the-blanks about a treatment for HSV (Herpes Simplex Virus).
Answer
In addition to antiviral medications or combination monoclonal antibodies, humanized antibodies can be used as a protein therapeutic to treat HSV.
Humanized antibodies against a surface protein of HSV, in addition to antiviral medications or combination monoclonal antibodies, can be used as a protein therapeutic to treat HSV.
Answer for screen readers
Humanized antibodies against a surface protein of HSV, in addition to antiviral medications or combination monoclonal antibodies, can be used as a protein therapeutic to treat HSV.
More Information
Monoclonal antibodies (mAbs) can improve the standardization of antibodies, which can improve the clinical management of herpesvirus reactivations.
Tips
Pay attention to the specific wording of the question. The question asks what humanized antibodies can be used in addition to. The answer should list therapies that can be used in conjunction with humanized antibodies.
Sources
- Overcoming drug-resistant herpes simplex virus (HSV) infection by a ... - pmc.ncbi.nlm.nih.gov
- A potent neutralizing and protective antibody against a conserved ... - sciencedirect.com
- Development of a highly effective combination monoclonal antibody ... - jbiomedsci.biomedcentral.com
AI-generated content may contain errors. Please verify critical information
